Skip to main content
N

Nusantics

Nusantics develops precision molecular diagnostics using PCR and NGS technologies to detect high-risk human papillomavirus (hrHPV) for cervical cancer screening and to provide early disease detection solutions for shrimp farming. Their products aim to reduce the incidence of cervical cancer and minimize economic losses in shrimp aquaculture caused by disease outbreaks.

Jakarta, IndonesiaFounded 20209300+ followers
Updated 4 months ago

Funding

$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Cervical cancer remains a significant health concern in Indonesia, often detected late due to limited access to effective and convenient screening methods. Shrimp aquaculture in Indonesia suffers substantial economic losses from disease outbreaks, requiring rapid and accurate diagnostic tools for early detection and prevention.

Solution

Nusantics develops and commercializes molecular diagnostic solutions based on PCR and NGS technologies, addressing critical needs in human health and animal aquaculture. For cervical cancer screening, their PathoScan hrHPV qPCR kit enables the detection of high-risk HPV types from urine and cervical swab samples, facilitating early diagnosis and intervention. For shrimp farming, their ShrimProtect AHPND/EMS product provides early disease detection, helping farmers to proactively manage and mitigate disease outbreaks, thereby minimizing economic losses.

Target Audience

The primary target audience includes healthcare providers and laboratories involved in cervical cancer screening, as well as shrimp farmers and aquaculture businesses seeking to minimize losses from disease outbreaks.

Features

  • PathoScan hrHPV qPCR kit for detecting 14 high-risk HPV types using urine and cervical swab samples.
  • ShrimProtect AHPND/EMS for early detection of Acute Hepatopancreatic Necrosis Disease (AHPND) and Early Mortality Syndrome (EMS) in shrimp.
  • Utilizes PCR and NGS technologies for precise and reliable molecular diagnostics.
  • Offers solutions for both human diagnostics (reproductive health, respiratory) and animal diagnostics (shrimp).
  • Provides early disease detection to support timely intervention and management.
This profile is AI-generated and may contain inaccuracies.